Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge
- PMID: 12444154
- DOI: 10.4049/jimmunol.169.11.6452
Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge
Abstract
IL-5 is a key cytokine for eosinophil maturation, recruitment, activation, and possibly the development of inflammation in asthma. High concentrations of IL-5 are present in the airway after Ag challenge, but the responsiveness of airway eosinophils to IL-5 is not well characterized. The objectives of this study were to establish, following airway Ag challenge: 1) the expression of membrane (m)IL-5Ralpha on bronchoalveolar lavage (BAL) eosinophils; 2) the responsiveness of these cells to exogenous IL-5; and 3) the presence of soluble (s)IL-5Ralpha in BAL fluid. To accomplish these goals, blood and BAL eosinophils were obtained from atopic subjects 48 h after segmental bronchoprovocation with Ag. There was a striking reduction in mIL-5Ralpha on airway eosinophils compared with circulating cells. Furthermore, sIL-5Ralpha concentrations were elevated in BAL fluid, but steady state levels of sIL-5Ralpha mRNA were not increased in BAL compared with blood eosinophils. Finally, BAL eosinophils were refractory to IL-5 for ex vivo degranulation, suggesting that the reduction in mIL-5Ralpha on BAL eosinophils may regulate IL-5-mediated eosinophil functions. Together, the loss of mIL-5Ralpha, the presence of sIL-5Ralpha, and the blunted functional response (degranulation) of eosinophils to IL-5 suggest that when eosinophils are recruited to the airway, regulation of their functions becomes IL-5 independent. These observations provide a potential explanation for the inability of anti-IL-5 therapy to suppress airway hyperresponsiveness to inhaled Ag, despite a reduction in eosinophil recruitment.
Similar articles
-
Decreased expression of membrane IL-5 receptor alpha on human eosinophils: II. IL-5 down-modulates its receptor via a proteinase-mediated process.J Immunol. 2002 Dec 1;169(11):6459-66. doi: 10.4049/jimmunol.169.11.6459. J Immunol. 2002. PMID: 12444155
-
Interleukin-5 receptors on human lung eosinophils after segmental allergen challenge.Clin Exp Allergy. 2004 Jul;34(7):1064-70. doi: 10.1111/j.1365-2222.2004.01986.x. Clin Exp Allergy. 2004. PMID: 15248851
-
Allergen-induced airway inflammation and bronchial responsiveness in interleukin-5 receptor alpha chain-deficient mice.Clin Exp Allergy. 2000 Jun;30(6):874-81. doi: 10.1046/j.1365-2222.2000.00828.x. Clin Exp Allergy. 2000. PMID: 10848907
-
IL-5 and IL-5 receptor in asthma.Mem Inst Oswaldo Cruz. 1997;92 Suppl 2:75-91. doi: 10.1590/s0074-02761997000800012. Mem Inst Oswaldo Cruz. 1997. PMID: 9698919 Review.
-
Eosinophil Activation Status in Separate Compartments and Association with Asthma.Front Med (Lausanne). 2017 Jun 12;4:75. doi: 10.3389/fmed.2017.00075. eCollection 2017. Front Med (Lausanne). 2017. PMID: 28660189 Free PMC article. Review.
Cited by
-
Monoclonal antibodies and other biologic agents in the treatment of asthma.MAbs. 2009 May-Jun;1(3):237-46. doi: 10.4161/mabs.1.3.8352. Epub 2009 May 4. MAbs. 2009. PMID: 20065638 Free PMC article. Review.
-
Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.J Allergy Clin Immunol. 2019 Jun;143(6):2227-2237.e10. doi: 10.1016/j.jaci.2018.10.066. Epub 2018 Dec 10. J Allergy Clin Immunol. 2019. PMID: 30543818 Free PMC article.
-
Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice.J Allergy Clin Immunol. 2023 Aug;152(2):469-485.e10. doi: 10.1016/j.jaci.2023.03.023. Epub 2023 Apr 6. J Allergy Clin Immunol. 2023. PMID: 37028525 Free PMC article.
-
Autophagy Protects against Eosinophil Cytolysis and Release of DNA.Cells. 2022 Jun 2;11(11):1821. doi: 10.3390/cells11111821. Cells. 2022. PMID: 35681515 Free PMC article.
-
Differential effects of short- and long-term treatment with mepolizumab on eosinophil kinetics in blood and sputum in eosinophilic asthma.iScience. 2021 Jul 28;24(8):102913. doi: 10.1016/j.isci.2021.102913. eCollection 2021 Aug 20. iScience. 2021. PMID: 34409272 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases